🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety and tolerability at increasing dose levels of PF-06863...
Status
Completed
Location
UCSD Medical Center - Encinitas
Start Date
2017-11-29
Trial ID
NCT03269136
The purpose of this study is to determine the effects that Elranatamab in c...
Status
Recruiting
Location
University of Miami
Start Date
2025-09-16
Trial ID
NCT06997081
Treatments Being Tested
Elranatamab is a bispecific antibody: binding of elranatamab to CD3-express...
Status
Recruiting
Location
Jupiter Medical Center/Anderson Family Cancer Institute
Start Date
2022-11-10
Trial ID
NCT05623020
Treatments Being Tested
This study is designed as a multicenter, randomized, parallel groups, open-...
Status
Recruiting
Location
CHU Amiens
Start Date
2025-07-09
Trial ID
NCT06918002
A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2019-08-09
Trial ID
NCT04068597
This research study is being done to compare the efficacy and safety of the...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-08-01
Trial ID
NCT07247097
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bis...
Status
Recruiting
Location
Clovis Community Medical Center
Start Date
2021-10-04
Trial ID
NCT05020236
Treatments Being Tested
The purpose of this study is to determine the Recommended Phase 2 Dose and ...
Status
Terminated
Location
Banner Gateway Medical Center
Start Date
2021-10-27
Trial ID
NCT05090566
Treatments Being Tested
The purpose of this study is to learn about the study medicine called elran...
Status
Recruiting
Location
Infirmary Cancer Care
Start Date
2024-02-08
Trial ID
NCT06152575
Treatments Being Tested